Back to Search
Start Over
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
- Source :
- Gut Microbes. 15
- Publication Year :
- 2023
- Publisher :
- Informa UK Limited, 2023.
-
Abstract
- Many patients with hematological malignancies, such as acute myeloid leukemia, receive an allogeneic hematopoietic cell transplantation (HCT) to cure their underlying condition. Allogeneic HCT recipients are exposed to various elements during the pre-, peri- and post-transplant period that can disrupt intestinal microbiota, including chemo- and radiotherapy, antibiotics, and dietary changes. The dysbiotic post-HCT microbiome is characterized by low fecal microbial diversity, loss of anaerobic commensals, and intestinal domination, particularly by Enterococcus species, and is associated with poor transplant outcomes. Graft-versus-host disease (GvHD) is a frequent complication of allogeneic HCT caused by immunologic disparity between donor and host cells and results in tissue damage and inflammation. Microbiota injury is particularly pronounced in allogeneic HCT recipients who go on to develop GvHD. At present, manipulation of the microbiome for example, via dietary interventions, antibiotic stewardship, prebiotics, probiotics, or fecal microbiota transplantation, is widely being explored to prevent or treat gastrointestinal GvHD. This review discusses current insights into the role of the microbiome in GvHD pathogenesis and summarizes interventions to prevent and treat microbiota injury.
Details
- ISSN :
- 19490984 and 19490976
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Gut Microbes
- Accession number :
- edsair.doi.dedup.....f802cd248be254952924a4613274b798
- Full Text :
- https://doi.org/10.1080/19490976.2023.2178805